|
|
Volumn 326, Issue 7381, 2003, Pages 120-
|
|
Company launches campaign to "counter" BMJ claims.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CGMP BINDING, CGMP SPECIFIC 3',5' CYCLIC NUCLEOTIDE PHOSPHODIESTERASE;
CGMP-BINDING, CGMP-SPECIFIC 3',5'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE;
CYCLIC GMP PHOSPHODIESTERASE;
PHOSPHODIESTERASE INHIBITOR;
ARTICLE;
DRUG ANTAGONISM;
DRUG INDUSTRY;
FEMALE;
FINANCIAL MANAGEMENT;
HUMAN;
PUBLIC RELATIONS;
PUBLICATION;
SEXUAL DYSFUNCTION;
3',5'-CYCLIC-GMP PHOSPHODIESTERASE;
DRUG INDUSTRY;
FEMALE;
HUMANS;
PERIODICALS;
PHOSPHODIESTERASE INHIBITORS;
PUBLIC RELATIONS;
RESEARCH SUPPORT;
SEXUAL DYSFUNCTION, PHYSIOLOGICAL;
MLCS;
MLOWN;
|
|
EID: 0037452304
PISSN: None
EISSN: 14685833
Source Type: Journal
DOI: 10.1136/bmj.326.7381.120/a Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|
